SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-032800
Filing Date
2021-06-14
Accepted
2021-06-14 16:52:49
Documents
13
Period of Report
2021-06-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-8k_20210610.htm   iXBRL 8-K 164123
2 EX-3.1 crsp-ex31_6.htm EX-3.1 386081
  Complete submission text file 0001564590-21-032800.txt   745450

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crsp-20210610.xsd EX-101.SCH 5776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20210610_lab.xml EX-101.LAB 19391
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20210610_pre.xml EX-101.PRE 11603
6 EXTRACTED XBRL INSTANCE DOCUMENT crsp-8k_20210610_htm.xml XML 3529
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 211015185
SIC: 2836 Biological Products, (No Diagnostic Substances)